The battle against chronic diseases is gaining momentum with the rise of the Implantable Drug-Eluting Devices Market. These innovative medical technologies are revolutionizing patient care by providing sustained drug delivery. According to a recent analysis by Future Market Insights (FMI), the market is projected to reach a staggering USD 19.3 billion by 2029, reflecting a robust Compound Annual Growth Rate (CAGR) of 6.0%.
https://www.futuremarketinsigh....ts.com/reports/sampl
https://www.futuremarketinsigh....ts.com/reports/impla